Welcome to our dedicated page for Petmed Express news (Ticker: PETS), a resource for investors and traders seeking the latest updates and insights on Petmed Express stock.
PetMed Express, Inc. reports developments tied to its PetMeds pet pharmacy platform, its PetCareRx business, and the sale of prescription and non-prescription pet medications, preventatives, health products, and supplies. The company serves pet owners through direct-to-consumer channels and has announced distribution partnerships that extend pet pharmacy offerings across retail and digital channels.
Recurring news themes include product assortments focused on pet wellness, fiscal results and financial reporting updates, Nasdaq listing-rule communications related to periodic filings, board and audit committee changes, shareholder rights plan actions, and responses to unsolicited acquisition proposals. Coverage also reflects the company's positioning as a national pet pharmacy and pet health products retailer.
PetMed Express (NASDAQ: PETS) will report its financial results for Q1 2020 on July 20, 2020, at 8:00 A.M. ET. A conference call led by CEO Menderes Akdag will follow at 8:30 A.M. ET, accessible via phone at (888) 455-1758 or (203) 827-7025 with passcode PETMEDS. For those unable to attend live, a replay will be available from 10:00 A.M. ET on the same day until August 3, 2020.
Founded in 1996, PetMed Express is a leading online pet pharmacy, providing a range of medications and health products for pets.